Qualifying Therapeutic Discovery Project Grants for the State of Delaware
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Incyte Corporation | Development of INCB24360 as a treatment for cancerous solid tumors. | $ 244,479.25 | |
| Incyte Corporation | Development of INCB7839 as a treatment for metastatic breast cancer. | $ 244,479.25 | |
| Incyte Corporation | Development of INCB18424 as a treatment for myelofibrosis | $ 244,479.25 | |
| Lake Biosciences LLC | Nerve Stimulation for the Treatment of Stroke | $ 217,500.00 | |
| Lake Biosciences LLC | Haptoglobin Type as a Prognostic Test for Vasospasm After Subarachnoid Hemorrhage | $ 102,500.00 | |
| OrPro Therapeutics, Inc | ORP100 Inhaled Mucolytic | $ 24,000.00 | |
| QPS Holdings LLC | Octreotide Phytate for Injectable Suspension (OPIS) | $ 129,669.47 | $ 104,738.52 |
| QPS Holdings, LLC | Leuprolide Mesylate for Injectable Suspension (LMIS) | $ 81,053.15 | $ 110,893.23 |
| QPS Holdings, LLC | Design, synthesis and development of highly selective matrix metalloprotease inhibitors | $ 96,431.23 | $ 62,375.43 |
| Respiratory Management Technology, Inc | Aerosol-Dispersion | $ 6,747.22 | $ 237,732.03 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
